|
BRD3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.497800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.294000E-01 |
| Normal-vs-Stage2 |
9.882400E-01 |
| Normal-vs-Stage3 |
9.038000E-01 |
| Normal-vs-Stage4 |
5.391000E-01 |
| Stage1-vs-Stage2 |
8.558000E-01 |
| Stage1-vs-Stage3 |
7.236000E-01 |
| Stage1-vs-Stage4 |
6.108200E-01 |
| Stage2-vs-Stage3 |
9.089000E-01 |
| Stage2-vs-Stage4 |
5.501400E-01 |
| Stage3-vs-Stage4 |
5.874800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.834600E-01 |
| Normal-vs-AfricanAmerican |
9.540000E-01 |
| Normal-vs-Asian |
6.844000E-03 |
| Caucasian-vs-AfricanAmerican |
6.363400E-01 |
| Caucasian-vs-Asian |
1.126970E-01 |
| AfricanAmerican-vs-Asian |
4.028200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.456600E-01 |
| Normal-vs-Female |
3.574800E-01 |
| Male-vs-Female |
4.152800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.151400E-01 |
| Normal-vs-Extreme_Weight |
6.592600E-01 |
| Normal-vs-Obese |
8.890400E-02 |
| Normal-vs-Extreme_Obese |
4.212000E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.475000E-01 |
| Normal_Weight-vs-Obese |
1.278000E-02 |
| Normal_Weight-vs-Extreme_Obese |
8.958400E-01 |
| Extreme_Weight-vs-Obese |
4.589500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.582400E-01 |
| Obese-vs-Extreme_Obese |
2.192200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.223000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.847600E-02 |
| Normal-vs-Age(61-80Yrs) |
2.913800E-01 |
| Normal-vs-Age(81-100Yrs) |
6.024300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.234000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.892000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.141700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.762200E-04 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.569700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.243200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.732100E-02 |
| Normal-VS-Type2 PRCC |
2.042400E-03 |
| Normal-VS-KIRP CIMP |
3.894200E-01 |
| Normal-VS-Unclassified PRCC |
1.797610E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.44830000506857E-09 |
| Type1 PRCC-VS-KIRP CIMP |
9.716000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.764800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.576400E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
6.211600E-04 |
| KIRP CIMP-VS-Unclassified PRCC |
9.859400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.205600E-02 |
| Normal-vs-N1 |
5.208400E-01 |
| Normal-vs-N2 |
7.740600E-01 |
| N0-vs-N1 |
7.938200E-02 |
| N0-vs-N2 |
3.467400E-01 |
| N1-vs-N2 |
9.075600E-01 |
|
|
